Literature DB >> 10637436

From PTK-STAT signaling to caspase expression and apoptosis induction.

X Y Fu1.   

Abstract

The cell growth and survival can be regulated by cytokine induced signals. Nevertheless, the molecular mechanisms of signal transduction from cytokine receptors to mediators of cell growth and apoptosis are not well characterized. STAT (signal transducer and activator of transcription) proteins can be activated by protein tyrosine kinases (PTK) in response to a variety of cytokines. We have shown that STAT activation induces expression of caspases which may cause cells undergo apoptosis. A hypothesis is proposed that PTKSTAT signaling pathways can regulate induction of apoptosis in response to cytokines and other extracellular signals.

Mesh:

Substances:

Year:  1999        PMID: 10637436     DOI: 10.1038/sj.cdd.4400613

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  12 in total

1.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning.

Authors:  John C Dreixler; Anthony Bratton; Eugenie Du; Afzhal R Shaikh; Brian Savoie; Michael Alexander; Marcus M Marcet; Steven Roth
Journal:  Exp Eye Res       Date:  2010-11-20       Impact factor: 3.467

2.  Blockade of glioma proliferation through allosteric inhibition of JAK2.

Authors:  Kunyan He; Qi Qi; Chi-Bun Chan; Ge Xiao; Xia Liu; Carol Tucker-Burden; Liya Wang; Hui Mao; Xiang Lu; Frank E McDonald; Hongbo Luo; Qi-Wen Fan; William A Weiss; Shi-Yong Sun; Daniel J Brat; Keqiang Ye
Journal:  Sci Signal       Date:  2013-07-09       Impact factor: 8.192

3.  Procaspase 8 and Bax are up-regulated by distinct pathways in Streptococcal pyrogenic exotoxin B-induced apoptosis.

Authors:  Chia-Wen Chang; Wan-Hua Tsai; Woei-Jer Chuang; Yee-Shin Lin; Jiunn-Jong Wu; Ching-Chuan Liu; Pei-Jane Tsai; Ming T Lin
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

4.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

5.  Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.

Authors:  Hui-Wen Lo; Xinyu Cao; Hu Zhu; Francis Ali-Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

6.  MAPK signaling during Müller glial cell development in retina explant cultures.

Authors:  Samuel Shao-Min Zhang; Hong Li; Ping Huang; Lucy Xi Lou; Xin-Yuan Fu; Colin J Barnstable
Journal:  J Ocul Biol Dis Infor       Date:  2011-08-12

7.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.

Authors:  Hui-Wen Lo; Sheng-Chieh Hsu; Weiya Xia; Xinyu Cao; Jin-Yuan Shih; Yongkun Wei; James L Abbruzzese; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

8.  Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression.

Authors:  Yi-Jun Chen; Ming-Liang You; Qing-Yun Chong; Vijay Pandey; Qiu-Shi Zhuang; Dong-Xu Liu; Lan Ma; Tao Zhu; Peter E Lobie
Journal:  Int J Mol Sci       Date:  2017-06-15       Impact factor: 5.923

Review 9.  EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.

Authors:  Hui-Wen Lo
Journal:  Curr Mol Pharmacol       Date:  2010-01       Impact factor: 3.339

10.  STAT3 Target Genes Relevant to Human Cancers.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.